PubMed Health⌕ Search

PubMed · 16737025

The human embryo in vitro: recent progress.

Abstract

This article reviews current laboratory techniques and procedures used for in vitro fertilization (IVF). The review covered relevant peer-reviewed articles in areas of IVF and associated treatment methods, such as embryo culture, intracytoplasmic sperm injection (ICSI), assisted hatching, cryopreservation and preimplantation genetic diagnosis and in vitro maturation. The availability of sequential media makes it possible to culture embryos to the later stage of blastocyst. The use of ICSI vs. IVF alone in male factor infertility results in the production of more embryos with a higher implantation rate. As a result, ICSI has been used successfully worldwide to treat infertile men to enable them to father children. Lack of standardized criteria for patient selection has complicated attempts to qualify the therapeutic value of assisted hatching. There is a general consensus, however, that assisted hatching can be performed in patients following repeated failed fertilization and older women to assist blastocyst hatching, the final stage before uterine implantation. Preimplantation genetic diagnosis is offered to both fertile and infertile couples who are at risk of passing genetic defects to their children. There are a few reports of successful human pregnancies following in vitro maturation of immature oocytes. Over the last 2 decades, IVF and associated treatment methods have been developed and greatly improved. The efficacies of these laboratory procedures need to be evaluated to determine if the procedures used have beneficial outcomes in clinical practice.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Susanne Geary, Young S Moon. 2006. The human embryo in vitro: recent progress.. https://pubmed.ncbi.nlm.nih.gov/16737025/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

BACKGROUND: In fair-skinned Caucasian populations both the incidence and mortality rates of cutaneous melanoma have been increasing over the past decades. With adjuvant therapies still being under investigation, early detection is the only way to improve melanoma patient survival. The influence of incisional biopsies on melanoma patient survival has been discussed for many years. This study investigates both the influence of diagnostic biopsy type and the presence of residual tumor cells in the re-excision specimen on disease free and overall survival. METHODS: After (partial) removal of a pigmented skin lesion 471 patients were diagnosed with stage I/II melanoma and underwent re-excision and a sentinel node biopsy. All patients were followed prospectively, mean follow up >5 years. Patients were divided according to their diagnostic biopsy type (wide excision biopsy, narrow excision biopsy, excision biopsy with positive margins and incisional biopsy) and the presence of residual tumor cells in their re-excision specimen. Survival analysis was done using Cox's proportional hazard model adjusted for eight important confounders of melanoma patient survival. RESULTS: The diagnostic biopsy was wide in 279 patients, narrow in 109 patients, 52 patients underwent an excision biopsy with positive margins and 31 patients an incisional biopsy. In 41 patients residual tumor cells were present in the re-excision specimen. Both the diagnostic biopsy type and the presence of tumor cells in the re-excision specimen did not influence disease free and overall survival of melanoma patients. CONCLUSIONS: Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

Biopsy↗